RT Journal Article
SR Electronic
T1 Detailed Overview of the Buildout and Integration of an Automated High-Throughput CLIA Laboratory for SARS-CoV-2 Testing on a Large Urban Campus
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.13.21263214
DO 10.1101/2021.09.13.21263214
A1 Landaverde, Lena
A1 McIntyre, David
A1 Robson, James
A1 Fu, Dany
A1 Ortiz, Luis
A1 Chen, Rita
A1 Oliveira, Samuel M.D.
A1 Fan, Andy
A1 Barrett, Amy
A1 Burgay, Stephen P.
A1 Choate, Stephen
A1 Corbett, David
A1 Doucette-Stamm, Lynn
A1 Gonzales, Kevin
A1 Hamer, Davidson H.
A1 Huang, Lilly
A1 Huval, Shari
A1 Knight, Christopher
A1 Lindquist, Diane
A1 Lockard, Kelly
A1 Macdowell, Trevor L.
A1 Mauro, Elizabeth
A1 McGinty, Colleen
A1 Miller, Candice
A1 Monahan, Maura
A1 Moore, Randall
A1 Platt, Judy
A1 Roy, Jeffrey
A1 Schroeder, Tracey
A1 Tolan, Dean R.
A1 Zaia, Ann
A1 Brown, Robert A.
A1 Waters, Gloria
A1 Densmore, Douglas
A1 Klapperich, Catherine M.
YR 2021
UL http://medrxiv.org/content/early/2021/11/01/2021.09.13.21263214.abstract
AB In 2019, the first cases of SARS-CoV-2 were detected in Wuhan, China, and by early 2020 the cases were identified in the United States. SARS-CoV-2 infections increased in the US causing many states to implement stay-at-home orders and additional safety precautions to mitigate potential outbreaks. As policies changed throughout the pandemic and restrictions lifted, there was an increase in demand for Covid-19 testing which was costly, difficult to obtain, or had long turn-around times. Some academic institutions, including Boston University, created an on-campus Covid-19 screening protocol as part of planning for the safe return of students, faculty, and staff to campus with the option for in-person classes. At BU, we stood up an automated high-throughput clinical testing lab with the capacity to run 45,000 individual tests weekly by fall of 2020, with a purpose-built clinical testing laboratory, a multiplexed RT-PCR test, robotic instrumentation, and trained CLIA certified staff. There were challenges to overcome, including the supply chain issues for PPE testing materials, and equipment that were in high demand. The Boston University Clinical Testing Laboratory was operational at the start of the fall 2020 academic year. The lab performed over 1 million SARS-CoV-2 RT-PCR tests during the 2020-2021 academic year.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was used for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:CLIA is the oversight body for clinical testing laboratories. We adhere to all CLIA requirements.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon request.